Bryan Johnson

Bryan Johnson is an American technology entrepreneur, venture capitalist, and longevity-focused biohacker.

Bryan Johnson is an American technology entrepreneur, venture capitalist, and longevity-focused biohacker. He is best known as the founder of Braintree and the creator of the anti-ageing project Blueprint, which has drawn wide media attention for its strict health regimen and claims about biological age reversal. His other ventures include Kernel, a company focused on measuring brain activity, and OS Fund, a venture capital firm.

Early career and business ventures

Johnson became wealthy in the technology sector and is most closely associated with Braintree, the payments company he founded. Braintree later acquired Venmo and was sold to PayPal for $800 million. He later moved into venture capital and brain-computer interface research through OS Fund and Kernel.

Blueprint and longevity biohacking

Blueprint is Johnson's self-directed health and longevity program, built around strict routines, testing, supplements, and medical monitoring. He has described it as an effort to slow or reverse biological ageing. Media reports say he spends about $2 million a year on his anti-ageing routine. His public messaging around longevity is often framed by the slogan 'Don't Die'.

Public profile and media attention

Johnson has become a prominent public figure in the biohacking and longevity world, appearing in interviews, documentaries, and news coverage. Reporting often focuses on the scale, cost, and unusual details of his regimen.

Claims, criticism, and medical controversy

Johnson has made claims about improved biomarkers and reduced biological age, but these claims are based on his own project and have attracted scrutiny. Coverage has also noted side effects and the experimental nature of some interventions he has tried.